Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
暂无分享,去创建一个
A. Hinke | M. Hallek | T. Seufferlein | R. Hofheinz | G. von Wichert | U. Hacker | A. Hochhaus | D. Arnold | S. Kanzler | M. Moehler | C. Schimanski | T. Hoehler | J. Siebler